News & events

PIONEER convened its Annual General Assembly Meeting virtually on November 23rd and 24th, with over 60 members gathering online to report on the progress of their work packages and to exchange ideas. Discussion were focused on prioritisation of datasets...

Susan Evans Axelsson (PIONEER WP3) joins Clare Delmar from the Focal Therapy Clinic (prospective PIONEER data contributor) for OnFocus, a podcast series discussing the little known, less understood and often ignored issues facing men diagnosed with prostate cancer. For...

Calling all patients: What Outcomes are important for men with advanced prostate cancer? An interview study Are you an advanced prostate cancer patient? Are you currently receiving, or have received in the past, either ADT or Chemotherapy treatment since...

First Data Sharing Agreement signed with external data contributor Active Biotech AB. Active Biotech AB has now shared data collected in a phase 3 randomised, double blind, placebo controlled study of tasquinimod in men with metastatic castrate-resistant prostate cancer....

PIONEER convened its 3rd Annual General Assembly Meeting virtually with over 50 members gathering online to report on the progress of their work packages and to exchange ideas. In particular, attendees were asked to focus on how PIONEER can...

The COVID-19 pandemic is unlike anything seen before by modern healthcare professionals, scientists, patients and society in general. As of 14/4/20 there are 1,933,800 confirmed cases globally in 210 countries and 120,434 deaths¹. Given the necessary restrictions now placed...